UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

South Asians and Coronary Plaque Registry

Recruiting

Conditions: Heart Diseases
Coronary Artery Disease

First Posted Date: 2022-05-10

Last Posted Date: 2024-08-16

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 300

Registration Number: NCT05367297

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

Phase 3

Recruiting

Conditions: Anesthesia Complication
Propofol Adverse Reaction
Anesthesia; Adverse Effect
Anesthesia; Reaction
Anesthesia
Etomidate Adverse Reaction

Interventions: Drug: Admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7)
Drug: Admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2)

First Posted Date: 2022-05-03

Last Posted Date: 2024-07-22

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 200

Registration Number: NCT05358535

Locations: 🇺🇸
Clements University Hospital, Dallas, Texas, United States

Effect of Prophylactic TMR and RPNI on Neuroma and Phantom Limb Pain

Not Applicable

Withdrawn

Conditions: Residual Limbs
Neuroma Amputation
Phantom Limb Pain
Amputation

Interventions: Procedure: Regenerative Peripheral Nerve Interface
Procedure: Targeted Muscle Re-innervation
Procedure: Standard Post-Amputation Surgical Care

First Posted Date: 2022-04-25

Last Posted Date: 2023-12-05

Lead Sponsor: University of Texas Southwestern Medical Center

Registration Number: NCT05344261

Tofacitinib in Recurrent GBM Patients

Phase 3

Recruiting

Conditions: Glioblastoma

Interventions: Drug: Tofacitinib 10mg

First Posted Date: 2022-04-13

Last Posted Date: 2024-07-05

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 20

Registration Number: NCT05326464

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus

Phase 2

Recruiting

Conditions: Renal Cell Carcinoma

Interventions: Drug: Neoadjuvant Lenvatinib
Drug: Neoadjuvant Pembrolizumab
Procedure: Radical nephrectomy, IVC thrombectomy, retroperitoneal lymph node dissection
Drug: Adjuvant Pembrolizumab

First Posted Date: 2022-04-08

Last Posted Date: 2024-11-05

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 30

Registration Number: NCT05319015

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

UroLift System With SAbR for Prostate Cancer and BPH

Phase 1

Recruiting

Conditions: Prostate Cancer

Interventions: Device: Urolift
Radiation: SABR

First Posted Date: 2022-04-05

Last Posted Date: 2024-01-09

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 15

Registration Number: NCT05311527

Locations: 🇺🇸
University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States

Noninvasive Brain Stimulation in Mild Cognitive Impairment and Dementia

Not Applicable

Completed

Conditions: Mild Cognitive Impairment
Dementia
Alzheimer Disease

Interventions: Device: Active Transcranial direct current stimulation (STARStim 8)
Device: Sham Transcranial direct current stimulation (STARStim 8)

First Posted Date: 2022-03-08

Last Posted Date: 2024-08-09

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 34

Registration Number: NCT05270408

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care in Texas

Not Applicable

Terminated

Conditions: Suicidal Ideation

Interventions: Other: STAT-PC
Other: YST-III

First Posted Date: 2022-03-08

Last Posted Date: 2023-01-20

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 3

Registration Number: NCT05270785

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)

Phase 2

Recruiting

Conditions: Cocaine Use Disorder

Interventions: Drug: Extended-Release Naltrexone
Drug: Placebo (PLB) Injectable matched to XR-NTX
Drug: Placebo (PLB) Injectable matched to XR-BUP
Drug: Extended Release Buprenorphine

First Posted Date: 2022-03-02

Last Posted Date: 2024-04-22

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 426

Registration Number: NCT05262270

Locations: 🇺🇸
UCLA Vine Street Clinic, Los Angeles, California, United States
🇺🇸
UTSW Medical Center, Center for Depression Research and Clinical Care, Dallas, Texas, United States
🇺🇸
Berman Center for Outcomes and Clinical Research at Hennepin Healthcare, Minneapolis, Minnesota, United States

and more 9 locations

Remote Methadone Ingestion Surveillance Trial (RMIST)

Not Applicable

Not yet recruiting

Conditions: Opioid Use Disorder

Interventions: Other: RMIST

First Posted Date: 2022-02-28

Last Posted Date: 2024-10-11

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 60

Registration Number: NCT05259501

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy